Kestra Medical (KMTS) 10% Owner Jeff Schwartz Sells, Receives RSUs

What Happened
Jeffrey Lawrence Schwartz, identified as a 10% owner of Kestra Medical Technologies (KMTS), reported two transactions: a sale and a grant. On 2026-09-08 he sold 3,890 common shares in an open-market sale at a weighted average price of $25.18 per share for total proceeds of $97,942. On 2026-09-09 he was granted 7,217 restricted stock units (RSUs) (no purchase price), each convertible into one common share upon vesting.

Key Details

• Transaction dates: Sale on 2026-09-08; RSU grant on 2026-09-09. Form 4 filed 2026-09-10 (appears timely).
• Sale details: 3,890 shares; weighted average price $25.18; price range $24.91–$25.424. Proceeds reported ~$97,942.
• Grant details: 7,217 RSUs granted (code A). RSUs vest on September 9, 2027, subject to continued service.
• Footnotes: The sale was a nondiscretionary sell-to-cover to satisfy tax withholding on the RSU settlement (tax-withholding transaction). The filer can provide a breakdown of number of shares sold at each price within the stated range upon request.
• Reported holdings: Footnote indicates 25,172,338 shares are held directly by Bain Charger Holdings, L.P.; Mr. Schwartz is a partner of Bain Capital Investors, LLC and may be deemed to share voting/dispositive power over those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.

Context
This combination — an RSU grant followed by a small sell-to-cover — is a common administrative/tax-withholding action tied to equity awards and does not by itself signal a change in insider sentiment. As a 10% owner via an affiliated investment vehicle, Schwartz’s reported large institutional holdings are separate from these personal RSU transactions.